Skip to main content
Top
Published in: Clinical Rheumatology 4/2021

Open Access 01-04-2021 | Affective Disorder | Original Article

A cross-sectional study of sleep and depression in a rheumatoid arthritis population

Authors: Mark Hughes, Alan Chalk, Poonam Sharma, Sandeep Dahiya, James Galloway

Published in: Clinical Rheumatology | Issue 4/2021

Login to get access

Abstract

Objectives

To assess the prevalence of impaired sleep quality and depression in a rheumatoid arthritis population and determine their correlation with Disease Activity Score (DAS) and its components.

Methods

In this single-centre observational cross-sectional study, data was collected by the assessing clinician for DAS28, age and gender in various treatment groups according to use of csDMARDs, biologics and long-term steroids. Presence of impaired sleep quality and depression was assessed by the Pittsburgh Sleep Quality Index (PSQI) and Public Health Questionnaire 9 (PHQ 9). Correlation for DAS and its components with the outcomes was determined by Pearson’s correlation coefficient. Multivariate analysis was performed by logistic regression.

Results

Two hundred patients were included. The prevalence across all subgroups of poor sleep quality and depression were 86.5% and 30%, respectively, with a correlation coefficient of 0.69 between the two and poor sleep quality amongst all RA patients with comorbid depression. Multivariate analysis found only subjective DAS components, tender joint count (TJC) and patient global health visual analogue score (VAS) to significantly correlate with both outcomes. Age inversely correlated with depression. Long-term steroid use was associated with poorer sleep quality, but there was no significant effect of csDMARDs or biologics. There was no significant difference in prevalence of depression amongst treatment subgroups.

Conclusion

Poor sleep quality and to a lesser extent depression are prevalent in the general rheumatoid arthritis population. Patients would benefit from clinicians measuring these outcomes routinely as they constitute a significant non-inflammatory burden of living with rheumatoid disease.
Key Points
• Subjective components of DAS independently correlate with sleep quality and depression, while objective components do not.
• Poor sleep quality is highly prevalent in RA and present in all those with comorbid depression.
• Poor sleep quality and depression incidence in RA are much lower when DAS is low or remission.
Literature
1.
go back to reference Taylor-Gjevre RM, Gjevre JA, Nair B, Skomro R, Lim HJ (2011) Components of sleep quality and sleep fragmentation in rheumatoid arthritis and osteoarthritis. Musculoskeletal Care Taylor-Gjevre RM, Gjevre JA, Nair B, Skomro R, Lim HJ (2011) Components of sleep quality and sleep fragmentation in rheumatoid arthritis and osteoarthritis. Musculoskeletal Care
2.
go back to reference Bell JA, Kivimäki M, Bullmore ET, Steptoe A, Carvalho LA (2017) Repeated exposure to systemic inflammation and risk of new depressive symptoms among older adults. Transl Psychiatry Bell JA, Kivimäki M, Bullmore ET, Steptoe A, Carvalho LA (2017) Repeated exposure to systemic inflammation and risk of new depressive symptoms among older adults. Transl Psychiatry
3.
go back to reference Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B (2007) Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 370:851–858CrossRef Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B (2007) Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 370:851–858CrossRef
4.
go back to reference Matcham F, Davies R, Hotopf M, Hyrich KL, Norton S, Steer S, et al. (2018) The relationship between depression and biologic treatment response in rheumatoid arthritis: an analysis of the British Society for Rheumatology Biologics Register. Rheumatol (United Kingdom) Matcham F, Davies R, Hotopf M, Hyrich KL, Norton S, Steer S, et al. (2018) The relationship between depression and biologic treatment response in rheumatoid arthritis: an analysis of the British Society for Rheumatology Biologics Register. Rheumatol (United Kingdom)
5.
go back to reference Choy EHS, Calabrese LH. (2018) Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis. Rheumatology (United Kingdom) Choy EHS, Calabrese LH. (2018) Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis. Rheumatology (United Kingdom)
6.
go back to reference Traki L, Rostom S, Tahiri L, Bahiri R, Harzy T, Abouqal R, Hajjaj-Hassouni N (2014) Responsiveness of the EuroQol EQ-5D and Hospital Anxiety and Depression Scale (HADS) in rheumatoid arthritis patients receiving tocilizumab. Clin Rheumatol. 33:1055–1060CrossRef Traki L, Rostom S, Tahiri L, Bahiri R, Harzy T, Abouqal R, Hajjaj-Hassouni N (2014) Responsiveness of the EuroQol EQ-5D and Hospital Anxiety and Depression Scale (HADS) in rheumatoid arthritis patients receiving tocilizumab. Clin Rheumatol. 33:1055–1060CrossRef
7.
go back to reference Kahn M, Sheppes G, Sadeh A (2013) Sleep and emotions: bidirectional links and underlying mechanisms. International Journal of Psychophysiology. 89:218–228CrossRef Kahn M, Sheppes G, Sadeh A (2013) Sleep and emotions: bidirectional links and underlying mechanisms. International Journal of Psychophysiology. 89:218–228CrossRef
8.
go back to reference Paterson JL, Dorrian J, Ferguson SA, Jay SM, Lamond N, Murphy PJ, Campbell SS, Dawson D (2011) Changes in structural aspects of mood during 39-66h of sleep loss using matched controls. Appl Ergon. 42:196–201CrossRef Paterson JL, Dorrian J, Ferguson SA, Jay SM, Lamond N, Murphy PJ, Campbell SS, Dawson D (2011) Changes in structural aspects of mood during 39-66h of sleep loss using matched controls. Appl Ergon. 42:196–201CrossRef
9.
go back to reference Jansson M, Linton SJ (2006) The role of anxiety and depression in the development of insomnia: cross-sectional and prospective analyses. Psychology and Health. 21:383–397CrossRef Jansson M, Linton SJ (2006) The role of anxiety and depression in the development of insomnia: cross-sectional and prospective analyses. Psychology and Health. 21:383–397CrossRef
10.
go back to reference Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 28:193–213CrossRef Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 28:193–213CrossRef
11.
go back to reference Kroenke K, Spitzer RL, Williams JBW (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 16:606–613CrossRef Kroenke K, Spitzer RL, Williams JBW (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 16:606–613CrossRef
12.
go back to reference Sarıyıldız (2013) Sleep quality in rheumatoid arthritis: relationship between the disease severity, depression, functional status and the quality of life. J Clin Med Res Sarıyıldız (2013) Sleep quality in rheumatoid arthritis: relationship between the disease severity, depression, functional status and the quality of life. J Clin Med Res
13.
go back to reference Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry
14.
go back to reference Lee YC, Lu B, Edwards RR, Wasan AD, Nassikas NJ, Clauw DJ, et al. (2013) The role of sleep problems in central pain processing in rheumatoid arthritis. Arthritis Rheum Lee YC, Lu B, Edwards RR, Wasan AD, Nassikas NJ, Clauw DJ, et al. (2013) The role of sleep problems in central pain processing in rheumatoid arthritis. Arthritis Rheum
15.
go back to reference Pollard LC, Ibrahim F, Choy EH, Scott DL (2012) Pain thresholds in rheumatoid arthritis: the effect of tender point counts and disease duration. J Rheumatol. 39:28–31CrossRef Pollard LC, Ibrahim F, Choy EH, Scott DL (2012) Pain thresholds in rheumatoid arthritis: the effect of tender point counts and disease duration. J Rheumatol. 39:28–31CrossRef
16.
go back to reference Fan A, Pereira B, Tournadre A, Tatar Z, Malochet-Guinamand S, Mathieu S, Couderc M, Soubrier M, Dubost JJ (2017) Frequency of concomitant fibromyalgia in rheumatic diseases: monocentric study of 691 patients. Semin Arthritis Rheum. 47:129–132CrossRef Fan A, Pereira B, Tournadre A, Tatar Z, Malochet-Guinamand S, Mathieu S, Couderc M, Soubrier M, Dubost JJ (2017) Frequency of concomitant fibromyalgia in rheumatic diseases: monocentric study of 691 patients. Semin Arthritis Rheum. 47:129–132CrossRef
17.
go back to reference Gheita TA, Sayed S, Gheita HA, Kenawy SA (2016) Vitamin D status in rheumatoid arthritis patients: relation to clinical manifestations, disease activity, quality of life and fibromyalgia syndrome. Int J Rheum Dis. 19:294–299CrossRef Gheita TA, Sayed S, Gheita HA, Kenawy SA (2016) Vitamin D status in rheumatoid arthritis patients: relation to clinical manifestations, disease activity, quality of life and fibromyalgia syndrome. Int J Rheum Dis. 19:294–299CrossRef
18.
go back to reference Duffield SJ, Miller N, Zhao S, Goodson NJ (2018) Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) Duffield SJ, Miller N, Zhao S, Goodson NJ (2018) Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis. Rheumatology (Oxford)
19.
go back to reference Lenz TL (2014) Drugs that negatively affect sleep. American Journal of Lifestyle Medicine. 8:383–385CrossRef Lenz TL (2014) Drugs that negatively affect sleep. American Journal of Lifestyle Medicine. 8:383–385CrossRef
20.
go back to reference Smolen JS, Landewé R, Breedveld FC, Buch M, Burmester G, Dougados M, et al. (2014) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis [Internet]. 1;73(3):492 LP – 509. Available from: http://ard.bmj.com/content/73/3/492.abstract Smolen JS, Landewé R, Breedveld FC, Buch M, Burmester G, Dougados M, et al. (2014) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis [Internet]. 1;73(3):492 LP – 509. Available from: http://​ard.​bmj.​com/​content/​73/​3/​492.​abstract
21.
go back to reference Geenen R, Overman CL, Christensen R, Åsenlöf P, Capela S, Huisinga KL, et al. (2018) EULAR recommendations for the health professional’s approach to pain management in inflammatory arthritis and osteoarthritis. Ann Rheum Dis Geenen R, Overman CL, Christensen R, Åsenlöf P, Capela S, Huisinga KL, et al. (2018) EULAR recommendations for the health professional’s approach to pain management in inflammatory arthritis and osteoarthritis. Ann Rheum Dis
Metadata
Title
A cross-sectional study of sleep and depression in a rheumatoid arthritis population
Authors
Mark Hughes
Alan Chalk
Poonam Sharma
Sandeep Dahiya
James Galloway
Publication date
01-04-2021
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 4/2021
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05414-8

Other articles of this Issue 4/2021

Clinical Rheumatology 4/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.